Optimized combinatorial pMHC class II multimer labeling for precision immune monitoring of tumor-specific CD4 T cells in patients

BACKGROUND: With immunotherapy gaining increasing approval for treatment of different tumor types, scientists rely on cutting edge methods for the monitoring of immune responses and biomarker development in patients. Due to the lack of tools to efficiently detect rare circulating human tumor-specifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rockinger, Georg Alexander, Guillaume, Philippe, Cachot, Amélie, Saillard, Margaux, Speiser, Daniel E, Coukos, Georges, Harari, Alexandre, Romero, Pedro J, Schmidt, Julien, Jandus, Camilla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253008/
https://www.ncbi.nlm.nih.gov/pubmed/32448802
http://dx.doi.org/10.1136/jitc-2019-000435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253008/
https://www.ncbi.nlm.nih.gov/pubmed/32448802
http://dx.doi.org/10.1136/jitc-2019-000435

Ejemplares similares